Cargando…

Risk Factors and Treatments of Suprachoroidal Hemorrhage

Suprachoroidal hemorrhage (SCH) is a rare but serious sight-threatening complication of inner eye surgery. Despite continuous advances in treatment, visual prognosis remains poor. The disease has a more typical clinical presentation, the etiology and pathogenesis are not well defined, and intraopera...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Huaiyan, Gao, Yang, Fu, Wenzhong, Xu, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303137/
https://www.ncbi.nlm.nih.gov/pubmed/35872859
http://dx.doi.org/10.1155/2022/6539917
_version_ 1784751788465848320
author Jiang, Huaiyan
Gao, Yang
Fu, Wenzhong
Xu, Hongxia
author_facet Jiang, Huaiyan
Gao, Yang
Fu, Wenzhong
Xu, Hongxia
author_sort Jiang, Huaiyan
collection PubMed
description Suprachoroidal hemorrhage (SCH) is a rare but serious sight-threatening complication of inner eye surgery. Despite continuous advances in treatment, visual prognosis remains poor. The disease has a more typical clinical presentation, the etiology and pathogenesis are not well defined, and intraoperative ocular and systemic factors may induce fulminant SCH. To investigate risk factors and treatments of SCH-associated intraocular surgeries, summarize diagnosis, characteristics, management, and prevention of SCH developed during and after intraocular surgeries. A retrospective study of SCH occurred in six cases of intraocular surgeries including cataract, glaucoma, pars plana vitrectomy (PPV), and silicone oil removal surgery. Assess baseline systemic and ocular characteristics of SCH eyes. Analyze the second surgery timing and technique, and visual outcomes were measured. SCH occurred in six patients including five eyes during surgeries and one eye after the surgery. Three eyes that underwent cataract surgery had hard nucleuses (nuclear sclerotic 4+). One eye was due to hypotony during the vitrectomy procedure. One eye developed SCH when silicone oil was extracted from the eyeball. One eye developed delayed SCH after glaucoma surgery. Incision closure and anterior chamber deepening were performed. B-scan ultrasonography was used to diagnose SCH, and determine the timing and location of sclerotomy for the second surgery. Vitrectomy and sclerotomy were performed in five eyes. The median follow-up time was six months. The final best-corrected visual acuity (BCVA) was 0.3 in one eye, one eye had light perception with retinal adherence, and four eyes had no light perception with retinal detachment. The results showed that risk factors including advanced age, hypertension, taking anticoagulants, antiplatelet drugs, and cardiovascular drugs were systemic risk factors, and hard nucleus (nuclear sclerosis 4 +) cataract, long-term uncontrolled ocular hypertension glaucoma, vitrectomy, silicone oil removal, high myopia, aphakia, previous intraocular surgery, intraocular pressure during surgery, and others were ocular risk factors. The most important risk factor is a sudden drop in intraocular pressure during or after surgery. The outcome of visual acuity depends on retinal status. Because of the poor prognosis, the prevention of SCH is of utmost importance during intraocular surgery.
format Online
Article
Text
id pubmed-9303137
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93031372022-07-22 Risk Factors and Treatments of Suprachoroidal Hemorrhage Jiang, Huaiyan Gao, Yang Fu, Wenzhong Xu, Hongxia Biomed Res Int Research Article Suprachoroidal hemorrhage (SCH) is a rare but serious sight-threatening complication of inner eye surgery. Despite continuous advances in treatment, visual prognosis remains poor. The disease has a more typical clinical presentation, the etiology and pathogenesis are not well defined, and intraoperative ocular and systemic factors may induce fulminant SCH. To investigate risk factors and treatments of SCH-associated intraocular surgeries, summarize diagnosis, characteristics, management, and prevention of SCH developed during and after intraocular surgeries. A retrospective study of SCH occurred in six cases of intraocular surgeries including cataract, glaucoma, pars plana vitrectomy (PPV), and silicone oil removal surgery. Assess baseline systemic and ocular characteristics of SCH eyes. Analyze the second surgery timing and technique, and visual outcomes were measured. SCH occurred in six patients including five eyes during surgeries and one eye after the surgery. Three eyes that underwent cataract surgery had hard nucleuses (nuclear sclerotic 4+). One eye was due to hypotony during the vitrectomy procedure. One eye developed SCH when silicone oil was extracted from the eyeball. One eye developed delayed SCH after glaucoma surgery. Incision closure and anterior chamber deepening were performed. B-scan ultrasonography was used to diagnose SCH, and determine the timing and location of sclerotomy for the second surgery. Vitrectomy and sclerotomy were performed in five eyes. The median follow-up time was six months. The final best-corrected visual acuity (BCVA) was 0.3 in one eye, one eye had light perception with retinal adherence, and four eyes had no light perception with retinal detachment. The results showed that risk factors including advanced age, hypertension, taking anticoagulants, antiplatelet drugs, and cardiovascular drugs were systemic risk factors, and hard nucleus (nuclear sclerosis 4 +) cataract, long-term uncontrolled ocular hypertension glaucoma, vitrectomy, silicone oil removal, high myopia, aphakia, previous intraocular surgery, intraocular pressure during surgery, and others were ocular risk factors. The most important risk factor is a sudden drop in intraocular pressure during or after surgery. The outcome of visual acuity depends on retinal status. Because of the poor prognosis, the prevention of SCH is of utmost importance during intraocular surgery. Hindawi 2022-07-14 /pmc/articles/PMC9303137/ /pubmed/35872859 http://dx.doi.org/10.1155/2022/6539917 Text en Copyright © 2022 Huaiyan Jiang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jiang, Huaiyan
Gao, Yang
Fu, Wenzhong
Xu, Hongxia
Risk Factors and Treatments of Suprachoroidal Hemorrhage
title Risk Factors and Treatments of Suprachoroidal Hemorrhage
title_full Risk Factors and Treatments of Suprachoroidal Hemorrhage
title_fullStr Risk Factors and Treatments of Suprachoroidal Hemorrhage
title_full_unstemmed Risk Factors and Treatments of Suprachoroidal Hemorrhage
title_short Risk Factors and Treatments of Suprachoroidal Hemorrhage
title_sort risk factors and treatments of suprachoroidal hemorrhage
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303137/
https://www.ncbi.nlm.nih.gov/pubmed/35872859
http://dx.doi.org/10.1155/2022/6539917
work_keys_str_mv AT jianghuaiyan riskfactorsandtreatmentsofsuprachoroidalhemorrhage
AT gaoyang riskfactorsandtreatmentsofsuprachoroidalhemorrhage
AT fuwenzhong riskfactorsandtreatmentsofsuprachoroidalhemorrhage
AT xuhongxia riskfactorsandtreatmentsofsuprachoroidalhemorrhage